close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Sensome

News headline image
Sensome Announces Positive First-in-Human Study Results for In Situ Tumor Detection Technology for Lung Cancer
From Sensome
Via Business Wire
News headline image
Newly Published Study Shows Sensome Clot-Sensing Guidewire Accurately Reveals True Clot Make-Up in Fully Occluded Brain Vessels for First Time
From Sensome
Via Business Wire
News headline image
Sensome Announces Successful Proof‑of‑Concept Adding Its Biological Intelligence to Robotic Thrombectomy
From Sensome
Via Business Wire
News headline image
New Study Shows That Innovative Methodology Powered by Sensome Technology Successfully Monitors Cancer Progression
From Sensome
Via Business Wire
News headline image
Sensome Announces Enrollment Completion in First-in-Human Study of In Situ Tumor Detection System for Lung Cancer
From Sensome
Via Business Wire
News headline image
Sensome Announces Data From Two New Studies Showing Clot-Sensing Guidewire Successfully Identifies Fresh Clot to Support Decision-Making in Peripheral Artery Disease Treatment
From Sensome
Via Business Wire
News headline image
Sensome Announces First Patients Enrolled in First-in-Human Study Evaluating Feasibility of Real-Time, In Situ Tumor Confirmation System for Lung Cancer
From Sensome
Via Business Wire
News headline image
Sensome Signs Exclusive Commercial Distribution Agreement for Clot-Sensing Guidewire in Japan With Cosmotec
From Sensome
Via Business Wire
News headline image
First-in-Human Data for Sensome Clot-Sensing Guidewire Used in Ischemic Stroke Treatment Demonstrate Ability to Automate Clot Characterization With No Safety Issues
From Sensome
Via Business Wire
News headline image
Sensome Announces Initiation of Clinical Trial Assessing Its Tissue Microsensor Technology in Peripheral Artery Disease
From Sensome
Via Business Wire
News headline image
Sensome and Asahi Intecc Forge Partnership to Develop Next-Generation Smart Guidewire and Transform Stroke Treatment
From SENSOME
Via Business Wire
News headline image
Sensome Begins Human Trial for Its AI-Powered Stroke Guidewire
From Sensome
Via Business Wire
News headline image
Sensome Receives FDA “Breakthrough Device Designation” for its AI-powered Stroke Guidewire
From Sensome
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today